BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6315760)

  • 1. Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia.
    Illingworth DR; Alam NA; Lindsey S
    J Clin Endocrinol Metab; 1984 Jan; 58(1):206-11. PubMed ID: 6315760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal cortical function in homozygous familial hypercholesterolemia.
    Illingworth DR; Lees AM; Lees RS
    Metabolism; 1983 Nov; 32(11):1045-52. PubMed ID: 6312250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway.
    Laue L; Hoeg JM; Barnes K; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1987 Mar; 64(3):531-5. PubMed ID: 3029155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia.
    Illingworth DR; Kenny TA; Orwoll ES
    J Clin Endocrinol Metab; 1982 Jan; 54(1):27-33. PubMed ID: 7054218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia.
    Illingworth DR; Corbin D
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6291-4. PubMed ID: 2994068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal adrenocortical response to adrenocorticotrophic hormone in patients with homozygous familial hypercholesterolaemia.
    Allen JM; Thompson GR; Myant NB
    Clin Sci (Lond); 1983 Jul; 65(1):99-101. PubMed ID: 6303676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia.
    Prihoda JS; Pappu AS; Smith FE; Illingworth DR
    J Clin Endocrinol Metab; 1991 Mar; 72(3):567-74. PubMed ID: 1847705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH.
    Illingworth DR; Kenny TA; Connor WE; Orwoll ES
    J Lab Clin Med; 1982 Jul; 100(1):115-26. PubMed ID: 6283000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cortisol secretion in abetalipoproteinemia.
    Illingworth DR; Orwoll ES; Connor WE
    J Clin Endocrinol Metab; 1980 May; 50(5):977-9. PubMed ID: 6246140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocortical function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin).
    Fojo SS; Hoegg JM; Lackner KJ; Anchors JM; Bailey KR; Brewer HB
    Horm Metab Res; 1987 Dec; 19(12):648-52. PubMed ID: 2831127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between LDL receptor activity and development of coronary heart disease in Japanese cases with heterozygous familial hypercholesterolemia.
    Yamashita S; Kawamoto T; Ueyama Y; Funahashi T; Hara H; Hirobe K; Matsuzawa Y; Yamamoto A; Tarui S
    Artery; 1987; 15(1):24-43. PubMed ID: 3435251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
    J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of heterozygous familial hypercholesterolemia associated with hyperthyroidism: effects of triiodothyronine on low-density lipoprotein receptor and cholesterol synthesis.
    Haba T; Sakai Y; Koizumi J; Miyamoto S; Mabuchi H; Takeda R
    Metabolism; 1983 Dec; 32(12):1129-32. PubMed ID: 6316072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia.
    Illingworth DR; Alam NA; Sundberg EE; Hagemenas FC; Layman DL
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3475-9. PubMed ID: 6304711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity in expression of heterozygous familial hypercholesterolemia. Characterization of a unique kindred.
    Levy RA; Ostlund RE; Semenkovich CF; Witztum JL
    J Clin Invest; 1986 Jul; 78(1):96-101. PubMed ID: 3722389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of low density lipoprotein metabolism by transforming growth factor-beta mediates its effects on steroidogenesis in bovine adrenocortical cells in vitro.
    Hotta M; Baird A
    Endocrinology; 1987 Jul; 121(1):150-9. PubMed ID: 3036466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential expression of high and low density lipoprotein receptors in differentiating fetal rat adrenocortical cells in primary culture.
    Kahri AI; Heikkilä P; Ehnholm C; Ranki H; Kovanen PT
    Endocrinology; 1989 Jul; 125(1):68-75. PubMed ID: 2544415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of plasma levels of cortisol, dehydroepiandrosterone and pregnenolone sulphate in normal subjects and in patients with homozygous familial hypercholesterolaemia during ACTH infusion.
    Boizel R; de Peretti E; Cathiard AM; Halimi S; Bost M; Berthezene F; Saez JM
    Clin Endocrinol (Oxf); 1986 Oct; 25(4):363-71. PubMed ID: 3040299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.
    Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K
    J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.